Back to Report Store Home

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018

  • Published: Aug-2018
  • Report Code: GBIHC044IDB
  • Report Format: pdf

Description

List of Figures

Figure 1: Number of Products under Development for Pancreatic Cancer

Figure 2: Number of Products under Development by Companies, Pancreatic Cancer

Figure 3: Number of Products under Development by Universities/Institutes, Pancreatic Cancer

Figure 4: Number of Products under Development for Bile Duct Cancer (Cholangiocarcinoma)

Figure 5: Number of Products under Development by Companies, Bile Duct Cancer (Cholangiocarcinoma)

Figure 6: Number of Products under Development by Universities/Institutes, Bile Duct Cancer (Cholangiocarcinoma)

Figure 7: Number of Products by Top 10 Targets, Pancreatic Cancer

Figure 8: Number of Products by Stage and Top 10 Targets, Pancreatic Cancer

Figure 9: Number of Products by Top 10 Mechanism of Actions, Pancreatic Cancer

Figure 10: Number of Products by Stage and Top 10 Mechanism of Actions, Pancreatic Cancer

Figure 11: Number of Products by Top 10 Routes of Administration, Pancreatic Cancer

Figure 12: Number of Products by Stage and Top 10 Routes of Administration, Pancreatic Cancer

Figure 13: Number of Products by Top 10 Molecule Types, Pancreatic Cancer

Figure 14: Number of Products by Stage and Top 10 Molecule Types, Pancreatic Cancer

Figure 15: Number of Products by Top 10 Targets, Bile Duct Cancer (Cholangiocarcinoma)

Figure 16: Number of Products by Stage and Top 10 Targets, Bile Duct Cancer (Cholangiocarcinoma)

Figure 17: Number of Products by Top 10 Mechanism of Actions, Bile Duct Cancer (Cholangiocarcinoma)

Figure 18: Number of Products by Stage and Top 10 Mechanism of Actions, Bile Duct Cancer (Cholangiocarcinoma)

Figure 19: Number of Products by Routes of Administration, Bile Duct Cancer (Cholangiocarcinoma)

Figure 20: Number of Products by Stage and Routes of Administration, Bile Duct Cancer (Cholangiocarcinoma)

Figure 21: Number of Products by Top 10 Molecule Types, Bile Duct Cancer (Cholangiocarcinoma)

Figure 22: Number of Products by Stage and Top 10 Molecule Types, Bile Duct Cancer (Cholangiocarcinoma)

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$11985
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards